Investor Alert

New York Markets Open in:

Rigel Pharmaceuticals Inc.



Before the Bell

 --Quotes are delayed by 20 min

Oct 21, 2021, 4:13 a.m.





+0.12 +3.60%


Volume 1

Quotes are delayed by 20 min


Previous close

$ 3.33

$ 3.33


-0.01 -0.30%

Day low

Day high




52 week low

52 week high




Annual Financials for Rigel Pharmaceuticals Inc.


Fiscal year is January-December. All values USD millions. 20162017201820192020 5-year trend
Cash & Short Term Investments 74.77M115.75M128.54M98.08M57.33M
Cash Only 17.63M38.29M76.32M22.52M30.37M
Short-Term Investments 57.13M77.46M52.22M75.56M26.95M
Total Accounts Receivable --4.08M10.11M15.97M
Accounts Receivables, Net --4.08M10.11M15.97M
Accounts Receivables, Gross 0-4.08M10.11M15.97M
Bad Debt/Doubtful Accounts -----
Other Receivables -----
Inventories --894,0001.35M5.64M
Finished Goods --364,000544,000449,000
Work in Progress --530,000810,0001.19M
Raw Materials -----
Progress Payments & Other ----4M
Other Current Assets 1.45M1.68M3.48M9.46M10.05M
Miscellaneous Current Assets 1.45M1.68M3.48M9.46M10.05M
Total Current Assets 76.21M117.43M136.99M119.01M88.98M
20162017201820192020 5-year trend
Net Property, Plant & Equipment 1.16M875,0001.39M27.87M20.57M
Property, Plant & Equipment - Gross 19.95M13.15M-40.91M34.25M
Buildings -----
Land & Improvements -----
Computer Software and Equipment 1.28M1.32M-1.62M1.78M
Other Property, Plant & Equipment 682,000711,000-1.39M1.79M
Accumulated Depreciation 18.79M12.28M-13.05M13.68M
Total Investments and Advances -----
Other Long-Term Investments -----
Long-Term Note Receivable -----
Intangible Assets -----
Net Goodwill -----
Net Other Intangibles -----
Other Assets 764,000803,000735,000696,000824,000
Tangible Other Assets 764,000803,000735,000696,000824,000
Total Assets 78.13M119.11M139.11M147.57M110.38M

Liabilities & Shareholders' Equity

20162017201820192020 5-year trend
ST Debt & Current Portion LT Debt ---7.27M8.62M
Short Term Debt ---7.27M8.62M
Current Portion of Long Term Debt -----
Accounts Payable 5.56M2.64M6.39M4.15M3.71M
Income Tax Payable -----
Other Current Liabilities 17.03M15.7M21.34M46.79M28.51M
Dividends Payable -----
Accrued Payroll 4.09M7.06M9.95M8.82M9.59M
Miscellaneous Current Liabilities 12.94M8.64M11.39M37.97M18.92M
Total Current Liabilities 22.59M18.34M27.73M58.21M40.84M
Long-Term Debt ---29.04M30.47M
Long-Term Debt excl. Capitalized Leases ---9.81M19.82M
Non-Convertible Debt ---9.81M19.82M
Convertible Debt -----
Capitalized Lease Obligations -----
Provision for Risks & Charges -----
Deferred Taxes -----
Deferred Taxes - Credit -----
Deferred Taxes - Debit -----
Other Liabilities 519,000128,0001.5M6.5M5.05M
Other Liabilities (excl. Deferred Income) 519,000128,0001.5M6.5M5.05M
Deferred Income -----
Total Liabilities 23.11M18.47M29.23M93.75M76.35M
Non-Equity Reserves -----
Preferred Stock (Carrying Value) -----
Redeemable Preferred Stock -----
Non-Redeemable Preferred Stock -----
Common Equity (Total) 55.03M100.65M109.88M53.82M34.03M
Common Stock Par/Carry Value 100,000147,000167,000168,000169,000
Retained Earnings (1.06B)(1.14B)(1.21B)(1.28B)(1.31B)
ESOP Debt Guarantee -----
Cumulative Translation Adjustment/Unrealized For. Exch. Gain -----
Unrealized Gain/Loss Marketable Securities ---23,000(4,000)
Revaluation Reserves -----
Treasury Stock -----
Total Shareholders' Equity 55.03M100.65M109.88M53.82M34.03M
Accumulated Minority Interest -----
Total Equity 55.03M100.65M109.88M53.82M34.03M
Liabilities & Shareholders' Equity 78.13M119.11M139.11M147.57M110.38M
Trending Tickers
  • /zigman2/quotes/200467500/composite NVDA+6.01%
  • /zigman2/quotes/200164174/composite SNOA+85.40%
  • /zigman2/quotes/202092269/composite ENSC+35.46%
  • /zigman2/quotes/226465160/composite ALF-14.72%
  • /zigman2/quotes/207732364/composite MSFT+1.66%
Powered by StockTwits
Link to MarketWatch's Slice.